Both in Pharmaceuticals

Prelude Therapeutics Incorporated vs Galectin Therapeutics

Over the past year PRLD returned +144.0% and GALT returned −42.9%; their daily moves had a correlation of 0.15.

PRLD +144.0% GALT −42.9%Growth of $1, one year, split-adjusted
MetricPRLDGALT
Price$3.88$3.32
Market cap$309.6M$334.8M
Today−5.37%−5.68%
1 month+2.4%−11.7%
6 months−17.4%+46.3%
Year to date+33.8%−20.2%
1 year+145.6%−35.0%
Revenue growth (YoY)——
Gross margin100.0%—
Net margin−244.1%—
P/E (TTM)——
Price / sales13.8×—
Net cash$151.8M-$19.8M
Dividend yield——
Volatility (60d)75.4%65.6%
Short % of float13.2%13.7%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).